Seelos Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 3.87, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Seelos Therapeutics Inc in Jun 30 2024 quarter, has decreased to 94 days, compared to 103 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 469 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 2145 to 3045.

What is Receivable Turnover Ratio?
What is Seelos Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SEEL Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	-56.38 %	22.07 %	-	-	-
Y / Y Revenue Change	-10.26 %	-32.69 %	1562.5 %	1127.78 %	2105.26 %
Receivable Turnover Ratio (TTM)	3.87	3.55	4.35	4.92	4.48
SEEL's Total Ranking	# 3045	# 2145	# 2368	# 2345	# 2628
Accounts Receivable average collection period days	94	103	84	74	82
Seq. Receivable Change	-80.58 %	26.87 %	245.25 %	-48.72 %	-45.65 %
Seq. Revenue Change	-36.16 %	-11.43 %	50.45 %	5.49 %	-52.11 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 157
Healthcare Sector	# 470
Overall Market	# 3045

Receivable Turnover Ratio Statistics
High	Average	Low
750	62.75	2.53
(Dec 31 2019)		(Dec 31 2016)

SEEL Company Profile • Back to SEEL Efficiency Comparisons • Compare SEEL Receivables Turnover Ratio to its Competitors

Financial Statements
Seelos Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit SEEL's Balance sheet
Seelos Therapeutics Inc 's Sales TTM	$ 2 Millions	Visit SEEL's Income Statement
Sources of SEEL's Revenues		Visit SEEL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SEEL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SEEL's Growth Rates	SEEL's Roa	SEEL's Inventory Turnover Ratio	SEEL's Dividend Comparisons
SEEL's Profitability Ratios	SEEL's Roi	SEEL's Asset Turnover Ratio	SEEL's Dividend Growth
SEEL's Valuation Ratios	SEEL's Roe	SEEL's Financial Strength Ratios	SEEL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Sonida Senior Living Inc	30.09	$ 268.040 Millions	$ 8.908 Millions
Clearside Biomedical Inc	28.61	$ 7.524 Millions	$ 0.263 Millions
National Vision Holdings Inc	27.21	$ 2,033.015 Millions	$ 74.709 Millions
Cv Sciences Inc	26.63	$ 14.932 Millions	$ 0.561 Millions
Sab Biotherapeutics Inc	26.59	$ 2.780 Millions	$ 0.105 Millions
Orchestra Biomed Holdings Inc	25.05	$ 2.079 Millions	$ 0.083 Millions
Kymera Therapeutics Inc	23.61	$ 88.550 Millions	$ 3.750 Millions
Renalytix Plc	22.89	$ 2.289 Millions	$ 0.100 Millions
Agenus Inc	22.75	$ 159.630 Millions	$ 7.015 Millions
Kiniksa Pharmaceuticals International Plc	22.32	$ 338.930 Millions	$ 15.188 Millions
U S Physical Therapy Inc	22.07	$ 627.673 Millions	$ 28.444 Millions
Cytomx Therapeutics Inc	21.94	$ 119.569 Millions	$ 5.451 Millions
Vireo Growth Inc.	21.79	$ 98.044 Millions	$ 4.500 Millions
Bespoke Extracts Inc	21.65	$ 1.047 Millions	$ 0.048 Millions
Editas Medicine Inc	20.47	$ 67.033 Millions	$ 3.275 Millions
Neuraxis Inc	20.46	$ 2.267 Millions	$ 0.111 Millions
Dih Holding Us Inc	19.47	$ 112.297 Millions	$ 5.769 Millions
Inmed Pharmaceuticals Inc	18.51	$ 5.331 Millions	$ 0.288 Millions
Arcellx Inc	18.39	$ 144.745 Millions	$ 7.870 Millions
Innovative Eyewear Inc	18.25	$ 1.530 Millions	$ 0.084 Millions
Hookipa Pharma inc	18.18	$ 52.163 Millions	$ 2.870 Millions
Ginkgo Bioworks Holdings Inc	17.78	$ 184.335 Millions	$ 10.367 Millions
Recursion Pharmaceuticals Inc	17.44	$ 49.635 Millions	$ 2.846 Millions
Co diagnostics Inc	17.27	$ 9.137 Millions	$ 0.529 Millions
Medinotec Inc	17.25	$ 6.931 Millions	$ 0.402 Millions
Milestone Scientific Inc	17.23	$ 8.408 Millions	$ 0.488 Millions
Scynexis Inc	17.22	$ 9.666 Millions	$ 0.561 Millions
Innovage Holding Corp	17.03	$ 763.855 Millions	$ 44.846 Millions
Talkspace Inc	16.80	$ 171.081 Millions	$ 10.184 Millions
Lineage Cell Therapeutics Inc	16.62	$ 6.186 Millions	$ 0.372 Millions

Date modified: 2026-06-22T14:32:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.